Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The Journal of Headache and Pain
Published in: The Journal of Headache and Pain 1/2015

Open Access 01-12-2016 | Research article

The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache

Authors: Malgorzata Pihut, Ewa Ferendiuk, Michal Szewczyk, Katarzyna Kasprzyk, Mieszko Wieckiewicz

Published in: The Journal of Headache and Pain | Issue 1/2015

Login to get access

Abstract

Background

Temporomandibular joint dysfunction are often accompanied by symptoms of headache such as tension-type headache which is the most frequent spontaneous primary headache. Masseter muscle pain is commonly reported in this group. The purpose of the study was to assess the efficiency of intramuscular botulinum toxin type A injections for treating masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.

Methods

This prospective outcome study consisted of 42 subjects of both genders aged 19–48 years diagnosed with masseter muscle pain related to temporomandibular joint dysfunction and tension-type headache. The subjects were treated by the intramuscular injection of 21 U (mice units) of botulinum toxin type A (Botox, Allergan) in the area of the greatest cross-section surface of both masseter bellies. Pain intensity was evaluated using visual analogue scale (VAS) and verbal numerical rating scale (VNRS) 1 week before the treatment and 24 weeks after the treatment. The obtained data were analyzed using the Wilcoxon matched pairs test (p ≤ 0,005).

Results

The results of this study showed a decrease in the number of referred pain episodes including a decrease in pain in the temporal region bilaterally, a reduction of analgesic drugs intake as well as a decrease in reported values of VAS and VNRS after injections (p = 0,000).

Conclusions

The intramuscular botulinum toxin type A injections have been an efficient method of treatment for masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.
Literature
1.
Liu F, Steinkeler A (2013) Epidemiology, diagnosis, and treatment of temporomandibular disorders. Dent Clin North Am 57(3):465–479CrossRefPubMed
2.
Glaros A, Williams K, Lauste L (2005) The role of parafunctions, emotions and stress in predicting facial pain. J Am Dent Assoc 136:451–458CrossRefPubMed
3.
4.
Wu G, Chen L, Fei H, Su Y, Zhu G, Chen Y (2013) Psychological stress may contribute to temporomandibular joint disorder in rats. J Surg Res 183:223–229CrossRefPubMed
5.
Wieckiewicz M, Boening K, Wiland P, Shiau YY, Paradowska-Stolarz A (2015) Reported concepts for the treatment modalities and pain management of temporomandibular disorders. J Headache Pain 16(106):1–12
6.
Rai B, Kaur J (2013) Association between stress, sleep quality and temporomandibular joint dysfunction: simulated Mars mission. Oman Med J 3:216–219CrossRef
7.
Gatchel RJ, Peng YB, Peters ML, Fuchs PN, Turk DC (2007) The biopsychosocial approach to chronic pain: scientific advances and future directions. Psychol Bull 133:581–624CrossRefPubMed
8.
Dahan H, Shir Y, Velly A, Allison P (2015) Specific and number of comorbidities are associated with increased levels of temporomandibular pain intensity and duration. J Headache Pain 16(528):1–10
9.
Was A, Tucholska S (2011) Tension-type headache-psychological aspect. Neurologia Dziecieca 20(41):115–118
10.
Rosted P, Jřrgensen A, Bundgaard M (2010) Temporomandibular dysfunction can contribute to aggravation of tension-type headache: a case report. Acupunct Med 28(3):154–155CrossRefPubMed
11.
12.
Pihut M, Majewski P, Wisniewska G, Reron E (2011) Auriculo-vestibular symptoms related to structural and functional disorders of stomatognatic system. J Physiol Pharm 62(2):251–256
13.
Branco L, Santis T, Alfaya T, Goday C, Fraqoso Y, Bussadori S (2013) Association between headache and temporomandibular joint disorders in children and addolscennts. J Oral Sci 55(1):39–43CrossRefPubMed
14.
Mongin F, Ciccone G, Ibertis F, Negro C (2000) Personality characteristics and accompanying symptoms in temporomandibular dysfunction, headache and facial pain. J Orofac Pain 14(1):52–58
15.
Graff- Radford S, Bassiur J (2014) Temporomandibular disorders and headaches. Neurol Clin 32(2):525–527CrossRefPubMed
16.
Silva J, Brandăo K, Faleiros B, Tavares R, Lara P, Januzzi E, Carvalho A, Carvalho E, Gomes J, Leite F, Alves B, Gómez R, Teixeira A (2014) Temporo-mandibular disorders are an important comorbidity of migraine and may be clinically difficult to distinguish them from tension-type headache. Arq Neuropsiquiatr 72(2):99–103CrossRef
17.
Blumenfeld A, Schim J, Brower J (2010) Pure tension-type headache versus tension-type headache in the migraineur. Curr Pain Headache Rep 14(6):465–469CrossRefPubMed
18.
Mathew P, Mathew T (2011) Taking care of the challenging tension headache patient. Curr Pain Headache Rep 15(6):444–450CrossRefPubMed
19.
Lebedeva ER, Kobzeva NR, Gilev DV, Olesen J (2016) Factors Associated With Primary Headache According To Diagnosis, Sex, and Social Group. Headache 56(2):341-356.
20.
21.
Lipton R, Bigal M, Steiner T, Silberstein S, Olesen J (2004) Classification od primary headache. Neurology 63:427–435CrossRefPubMed
22.
Sato H, Saisu H, Muraoka W, Nakagawa T, Svensson P, Wajima K (2012) Lack of temporal summation but distinct after sensations to thermal stimulation in patients with combined tension-typeheadache and myofascial temporomandibular disorder. J Orofac Pain 26(4):288–295PubMed
23.
List T, John M, Ohrbach R, Schiffman E, Truelove E, Anderson G (2012) Influence of temple headache frequency on physical functioning and emotional functioning in subjects with temporomandibular disorder. Pain 26:283–290
24.
Blumenfeld A, Bender S, Glassman B, Malizia D (2011) Bruxism, temporomandibular dysfunction, tension type headache, and migraine: a comment. Headache 51(10):1549–1550CrossRefPubMed
25.
Evans R, Bassiur J, Schwartz A (2011) Bruxism, temporomandibular dysfunction, tension-type headache, and migraine. Headache 51(7):1169–1172CrossRefPubMed
26.
La Touche R, Paris-Alemany A, Gil-Martínez A, Pardo-Montero J, Angulo-Díaz-Parreño S, Fernández-Carnero J (2015) Masticatory sensory-motor changes after an experimental chewing test influenced by pain catastrophizing and neck-pain-related disability in patients with headache attributed to temporomandibular disorders. J Headache Pain 16(20):1–14
27.
Vilanova LS, Garcia RC, List T, Alstergren P (2015) Diagnostic criteria for temporomandibular disorders: self-instruction or formal training and calibration? J Headache Pain 16(505):1–9
28.
Dworkin SF, LeResche L (1992) Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandibular Sleep Pract 6(4):301–355
29.
Headache Classification Subcommittee of the International Headache Society (2005) The International Classification of Headache Disorders, 2nd edn
30.
Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH, Fainsinger R, Aass N, Kaasa S (2011) Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage 41(6):1073–1093CrossRefPubMed
31.
Goncalves D, Camparis C, Speciali J, Franco A, Castanharo S, Bigal M (2011) Tmeporomandibular joint disorders are differentially associated with headache diagnoses: a controlled study. Clin J Pain 27(7):611–615CrossRefPubMed
32.
Ashkenazi A, Blumenfeld A (2013) Onabotulinumtoxin A for the treatment of headache. Headache 53(2):54–61CrossRefPubMed
33.
Rollnik JD, Tanneberger O, Schubert M, Schneider U, Dengler R (2000) Treatment of tension type headache with botulinum toxin type A. Headache 40:300–305CrossRefPubMed
34.
Gady J, Ferneini E (2013) Botulinum toxin A and headache treatment. Conn Med 77(3):165–166PubMed
35.
Lippert-Grüner M (2012) Botulinum toxin in the treatment of post-traumatic headache - case study. Neurol Neurochir Pol 46(6):591–594PubMed
36.
Jackson J, Kuriyama A, Hayashino Y (2012) Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis. JAMA 307(16):1736–1745CrossRefPubMed
37.
Levy N, Lowenthal D (2012) Application of botulinum toxin to clinical therapy: advances and cautions. Am J Ther 19(4):281–286CrossRefPubMed
38.
39.
Denglehem C, Maes J, Raoul G, Ferri J (2012) Botulinum toxin A: analgesic treatment for temporomandibular joint disorders. Rev Stomatol Chir Maxillofac 113(1):27–31CrossRefPubMed
40.
Kotimäki J, Saarinen A (2011) Treatment of recurrent dislocation of the temporomandibular joint with botulinum toxin: an alternative approach. Duodecim 127(19):2088–2091PubMed
41.
Björling E (2009) Momentary relationship between stress and headache in adolescent girls. Headache 49:1186–1197CrossRefPubMed
42.
Yancey J, Sheridan R, Koren K (2014) Chronic daily headache:diagnosis and management. Am Farm Physician 15(89):642–648
43.
Singh N, Sahota P (2013) Sleep-related headache and its management. Curr Treat Options Neurol 15(6):704–722CrossRefPubMed
44.
Ashkenazi A, Blumenfeld A (2013) Onabotulinum toxin A for treatment of headache. Headache 53(Suppl. 2):54–61CrossRefPubMed
45.
Persaud R, Garas G, Silva S, Stamatoglou C, Chatrath P, Patel K (2013) An evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck conditions. JRSM Short Rep 4(2):10CrossRefPubMedPubMedCentral
46.
Mathew N, Kailasam J, Meadors L (2008) Botulinum toxin type A for the treatment of nummular headache:four case studies. Headache 48(3):442–447CrossRefPubMed
47.
Farinelli I, Coloprisco G, De Filippis S, Martelletti P (2006) Long term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five year long experience. J Headache Pain 7(6):407–412CrossRefPubMedPubMedCentral
48.
Christidis N, Omrani S, Fredriksson L, Gjelset M, Louca S, Hedenberg-Magnusson B, Ernberg M (2015) Repeated tender point injections of granisetron alleviate chronic myofascial pain--a randomized, controlled, double-blinded trial. J Headache Pain 16(104):1–13
49.
Kün-Darbois JD, Libouban H, Chappard D (2015) Botulinum toxin in masticatory muscles of the adult rat induces bone loss at the condyle and alveolar regions of the mandible associated with a bone proliferation at a muscle enthesis. Bone 77:75–82CrossRefPubMed
50.
Korfage JA, Wang J, Lie SH, Langenbach GE (2012) Influence of botulinum toxin on rabbit jaw muscle activity and anatomy. Muscle Nerve 45(5):684–691CrossRefPubMed
Metadata
Title
The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache
Authors
Malgorzata Pihut
Ewa Ferendiuk
Michal Szewczyk
Katarzyna Kasprzyk
Mieszko Wieckiewicz
Publication date
01-12-2016
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue 1/2015
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1186/s10194-016-0621-1

Other articles of this Issue 1/2015

The Journal of Headache and Pain 1/2015 Go to the issue

Research article

Onabotulinumtoxin-A treatment in Greek patients with chronic migraine

Erratum

Erratum to: Expression of messenger molecules and receptors in rat and human sphenopalatine ganglion indicating therapeutic targets

Research article

Structured education can improve primary-care management of headache: the first empirical evidence, from a controlled interventional study

Methodology

Pharmacology of reflex blinks in the rat: a novel model for headache research

Research article

Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series

Research article

Field testing primary stabbing headache criteria according to the 3rd beta edition of International Classification of Headache Disorders: a clinic-based study